Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{b95702fb263144e1b0715cd9bb3e379f,
title = "Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm",
abstract = "Diffuse alveolar hemorrhage (DAH) is a clinical syndrome with typical symptoms dyspnea and hemoptysis. DAH is a complication of specific diseases, in some cases with acute catastrophic hemoptysis, while other patients present low grade alveolar bleeding with a need of chronic transfusion as in pulmonary hemosiderosis.",
author = "Lars Heslet and Nielsen, {J{\o}rn Dalsgaard} and Steen Nepper-Christensen",
year = "2012",
doi = "10.2147/BTT.S25507",
language = "English",
volume = "6",
pages = "37--46",
journal = "Biologics (Online)",
issn = "1177-5491",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm

AU - Heslet, Lars

AU - Nielsen, Jørn Dalsgaard

AU - Nepper-Christensen, Steen

PY - 2012

Y1 - 2012

N2 - Diffuse alveolar hemorrhage (DAH) is a clinical syndrome with typical symptoms dyspnea and hemoptysis. DAH is a complication of specific diseases, in some cases with acute catastrophic hemoptysis, while other patients present low grade alveolar bleeding with a need of chronic transfusion as in pulmonary hemosiderosis.

AB - Diffuse alveolar hemorrhage (DAH) is a clinical syndrome with typical symptoms dyspnea and hemoptysis. DAH is a complication of specific diseases, in some cases with acute catastrophic hemoptysis, while other patients present low grade alveolar bleeding with a need of chronic transfusion as in pulmonary hemosiderosis.

U2 - 10.2147/BTT.S25507

DO - 10.2147/BTT.S25507

M3 - Journal article

C2 - 22419859

VL - 6

SP - 37

EP - 46

JO - Biologics (Online)

JF - Biologics (Online)

SN - 1177-5491

ER -

ID: 36526919